Condition: Atrial Fibrillation · Sponsor: Herlev and Gentofte Hospital
The purpose of this study to investigate the effects of colchicine on atrial fibrillation recurrence and vascular and cardiac function in patients with atrial fibrillation.
This description comes directly from the study's public registry record.
Adam Femerling Langhoff, M.D. · +4522552317 · adam.femerling.langhoff@regionh.dk
Tor Biering-Sørensen, MD, PhD, MPH · +4528933590 · tor.biering-soerensen@regionh.dk
Always discuss trial participation with your own doctor first.
| Center for Translational Cardiology and Pragmatic Randomized Trials (CTCPR) | Hellerup, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05928728